Favorite this paper
How to cite this paper?
Abstract

Introduction - Age-related changes in the immune system can affect the occurrence and clinical expression of autoimmune disorders. While some studies have explored neuromyelitis optica spectrum disorder (NMOSD) in older adults, analysis of "very late-onset NMOSD" (VLO-NMOSD), with onset at 70 years or older, remains limited to case. Objective - To assess the frequency, clinical characteristics, and outcomes of VLO-NMOSD patients in a large Latin American (LATAM) NMOSD cohort. Methods – The study included NMOSD patients meeting the 2015 IPND criteria from nine LATAM countries. Patients were categorized into VLO-NMOSD (≥70 years) and Non-VLO-NMOSD groups. We the demographic and clinical features of VLO-NMOSD with NMOSD onset at <70 years (Non-VLO-NMOSD). Results – Out of 1185 NMOSD patients, data on age at onset were available for 1179, with 14 (1.2%) in the VLO-NMOSD group. For these 14 patients the median age was 73 [71 - 83], 12 (85.7) were female, the most common presenting symptoms were myelitis and optic neuritis  [10 and 7], and median disease duration was 40.9 [9.0 – 149.0]. The median ARR was 0.37, and the median EDSS score was 6.0 ( 5.0 - 7.5). Compared to Non-VLO-NMOSD, VLO-NMOSD had a higher proportion of females and patients with mixed race/ethnicity, fewer Caucasians, more myelitis  and optic neuritis (71.4% vs.48.1%,  50% vs 48.1%). None of the VLO-NMOSD cases presented with area postrema, cerebral, or diencephalic syndromes. VLO-NMOSD had a lower ARR (0.37) and higher EDSS scores (p=0.004). Differences in other characteristics between the groups did not reach statistical significance. Conclusion - VLO-NMOSD is rare and demonstrates unique clinical characteristics with more severe outcomes. Notably, VLO-NMOSD in LATAM presents with optic neuritis more frequently at onset compared to other population series.

Share your ideas or questions with the authors!

Did you know that the greatest stimulus in scientific and cultural development is curiosity? Leave your questions or suggestions to the author!

Sign in to interact

Have a question or suggestion? Share your feedback with the authors!

Institutions
  • 1 CIEM MS Research Center, Federal University of Minas Gerais Medical School, Belo Horizonte, Brazil.
  • 2 Professor Edgar Santos University Hospital,Federal University of Bahia (UFBA), Salvador, Brazil.
  • 3 Hospital Geral de Fortaleza, Neuroimunology ,Fortaleza, Brazil.
  • 4 Centro Básico de Investigación em Demencia y Enfermedades Desmielinizantes del Sistema Nervioso, Lima, Peru
  • 5 Neurology Department, Dr. Ramón Carrillo Central Hospital, San Luis, Argentina.
  • 6 Centro Esclerosis Múltiple Buenos Aires (CEMBA), Buenos Aires, Argentina.
  • 7 Neuroimmunology Hospital de Clínicas “José de San Martín” University of Buenos Aires,, Buenos Aires, Argentina.
  • 8 Neuroimmunology Unit, Department of Neurosciences, Hospital Aleman, Buenos Aires, Argentina.
  • 9 Hospital da Restauração, Recife, Brazil
  • 10 Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP, Ribeirão Preto, Brazil
  • 11 .Faculdade de Ciências Médicas da Santa Casa de São Paulo
  • 12 Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil.
  • 13 Hospital Carlos Andrade Marin, e Pontificia Universidad católica del Ecuador (PUCE), Quito, Ecuador.
  • 14 Instituto Nacional de Ciencias Medicas y Nutricion “Salvador Zubirán” , Ciudad de México, Mexico.
  • 15 Clinica Universitaria Colombia, Bogotá, Colombia.
  • 16 Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, Brazil.
  • 17 Clínica Alemana y Universidad Del Desarrollo, Santiago, Chile.
  • 18 School of Medicine of the State University UDELAR, Montevideo, Uruguay.
  • 19 Pontifícia Universidade Católica de São Paulo, Sorocaba, Brazil.
  • 20 Pontificia Universidad Católica de Chile and Hospital Dr Sótero del Rio, Santiago, Chile.
  • 21 .BP
  • 22 Departament of Neurology - Neurovie, Joinville, Brazil.
  • 23 Hospital Britanico Buenos Aires, Buenos Aires, Argentina.
  • 24 Hospital Clinico, Maracaibo, Venezuela.
  • 25 Neurological Institute of Curitiba, Curitiba, Brazil.
  • 26 Hospital São Francisco na Providência de Deus
  • 27 University of Brasilia, Distrito Federal, Brazil
  • 28 Neurology Department - Hospital das Clínicas São Paulo University, Sao Paulo, Brazil.
  • 29 Santa Casa de Sao Paulo School of Medical Sciences, Sao Paulo, Brazil.
Track
  • 2. Epidemiology and MRI
Keywords
Neuromyelitis spectrum disorders
very late-onset NMOSD
Latin America
myelitis
optic neuritis